1. Home
  2. PLUR vs FTHM Comparison

PLUR vs FTHM Comparison

Compare PLUR & FTHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLUR
  • FTHM
  • Stock Information
  • Founded
  • PLUR 2001
  • FTHM 2010
  • Country
  • PLUR Israel
  • FTHM United States
  • Employees
  • PLUR N/A
  • FTHM N/A
  • Industry
  • PLUR Biotechnology: Biological Products (No Diagnostic Substances)
  • FTHM Real Estate
  • Sector
  • PLUR Health Care
  • FTHM Finance
  • Exchange
  • PLUR Nasdaq
  • FTHM Nasdaq
  • Market Cap
  • PLUR 37.6M
  • FTHM 38.3M
  • IPO Year
  • PLUR N/A
  • FTHM 2020
  • Fundamental
  • Price
  • PLUR $4.48
  • FTHM $1.69
  • Analyst Decision
  • PLUR Strong Buy
  • FTHM
  • Analyst Count
  • PLUR 1
  • FTHM 0
  • Target Price
  • PLUR $12.00
  • FTHM N/A
  • AVG Volume (30 Days)
  • PLUR 9.3K
  • FTHM 701.4K
  • Earning Date
  • PLUR 11-11-2025
  • FTHM 11-06-2025
  • Dividend Yield
  • PLUR N/A
  • FTHM N/A
  • EPS Growth
  • PLUR N/A
  • FTHM N/A
  • EPS
  • PLUR N/A
  • FTHM N/A
  • Revenue
  • PLUR $1,336,000.00
  • FTHM $390,032,000.00
  • Revenue This Year
  • PLUR $246.11
  • FTHM $25.22
  • Revenue Next Year
  • PLUR $169.62
  • FTHM $16.19
  • P/E Ratio
  • PLUR N/A
  • FTHM N/A
  • Revenue Growth
  • PLUR 309.82
  • FTHM 19.16
  • 52 Week Low
  • PLUR $3.33
  • FTHM $0.65
  • 52 Week High
  • PLUR $7.13
  • FTHM $3.37
  • Technical
  • Relative Strength Index (RSI)
  • PLUR 46.99
  • FTHM 42.40
  • Support Level
  • PLUR $4.08
  • FTHM $1.65
  • Resistance Level
  • PLUR $4.50
  • FTHM $1.94
  • Average True Range (ATR)
  • PLUR 0.22
  • FTHM 0.16
  • MACD
  • PLUR -0.02
  • FTHM -0.06
  • Stochastic Oscillator
  • PLUR 65.05
  • FTHM 7.03

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

About FTHM Fathom Holdings Inc.

Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.

Share on Social Networks: